Re:Shasqi (YC W15) aims to make chemotherapy more powerful a...
by mejiaoneto on Saturday October 17, 2020 @11:41AM
(#24810782)
Yes. Any solid tumor that is accesible for an injection and we have reason to suspect it would be sensitive to doxorubicin, would fit the criteria of this phase 1 study.
For more info on the clinical trial please visit:
https://clinicaltrials.gov/ct2/show/NCT04106492
https://en.wikipedia.org/wiki/Aggressive_fibromatosis